Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Tatsuki Tomikawa"'
Autor:
Kaito Harada, Makoto Onizuka, Takehiko Mori, Hiroaki Shimizu, Sachiko Seo, Nobuyuki Aotsuka, Yusuke Takeda, Noritaka Sekiya, Machiko Kusuda, Shinichiro Fujiwara, Sawako Shiraiwa, Katsuhiro Shono, Naoki Shingai, Heiwa Kanamori, Mamiko Momoki, Satoru Takada, Junichi Mukae, Shinichi Masuda, Kinuko Mitani, Emiko Sakaida, Tatsuki Tomikawa, Satoshi Takahashi, Kensuke Usuki, Yoshinobu Kanda
Publikováno v:
International Journal of Infectious Diseases, Vol 131, Iss , Pp 79-86 (2023)
Objectives: Influenza virus infection (IVI) occasionally causes lower respiratory tract infection (LRTI) in allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients. Although the progression to LRTI entails a high mortality, the role
Externí odkaz:
https://doaj.org/article/6c3e0d7a11da498db56a870f38832cd2
Autor:
Ken Ishiyama, Noriharu Nakagawa, Kensuke Usuki, Satoru Takada, Tatsuki Tomikawa, Hiroshi Handa, Yuna Katsuoka, Daiki Hirano, Nobuo Sezaki, Masahiko Sumi, Shin Fujisawa, Yasuhiro Taniguchi, Atsuko Mugitani, Takuro Yoshimura, Eiichi Ohtsuka, Ken Takase, Youko Suehiro, Shuichi Ota, Tomohiro Kajiguchi, Tomoya Maeda, Masahide Yamamoto, Shigeki Ohtake, Akira Katsumi, Hitoshi Kiyoi, Itaru Matsumura, Yasushi Miyazaki
Allogeneic hematopoietic stem cell transplantation (allo-SCT) is the sole curative therapy for myelodysplastic syndromes (MDS). However, whether bridging therapy (BRT) including azacitidine (AZA) and combination chemotherapy (CCT) prior to allo-SCT s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b739a6d580d7bb7f9e5237a9f936326c
https://doi.org/10.21203/rs.3.rs-2271688/v1
https://doi.org/10.21203/rs.3.rs-2271688/v1
Autor:
Masahiro Kizaki, Shuju Momose, Michihide Tokuhira, Morihiro Higashi, Reiko Nakaseko, Junichi Watanabe, Yasuyuki Takahashi, Jun-ichi Tamaru, Yuta Kimura, Yuka Tanaka, Koichi Amano, Takayuki Tabayashi, Morihiko Sagawa, Tatsuki Tomikawa, Tomoe Anan
Publikováno v:
Journal of Clinical and Experimental Hematopathology : JCEH
Regressive lymphoproliferative disorders (R-LPD) after methotrexate (MTX) withdrawal are one of the specific features of methotrexate - associated lymphoproliferative disorders (MTX-LPD). Although the impact of the absolute lymphocyte count (ALC) on
Autor:
Daiki Hirano, Takuro Yoshimura, Shin Fujisawa, Hitoshi Kiyoi, Masahiko Sumi, Yasuhiro Taniguchi, Eiichi Ohtsuka, Yasushi Miyazaki, Itaru Matsumura, Masahide Yamamoto, Akira Katsumi, Tomohiro Kajiguchi, Tomoya Maeda, Shuichi Ota, Nobuo Sezaki, Noriharu Nakagawa, Yuna Katsuoka, Ken Ishiyama, Ken Takase, Satoru Takada, Hiroshi Handa, Tatsuki Tomikawa, Youko Suehiro, Kensuke Usuki, Shigeki Ohtake
Publikováno v:
Blood. 138:2925-2925
Introduction: Allogeneic hematopoietic stem cell transplantation (allo-SCT) is the sole curative therapy for myelodysplastic syndromes (MDS). Several studies have addressed the efficacy of bridging therapy before allo-SCT including hypomethylating ag
Autor:
Reiko Watanabe, Yuta Kimura, Takayuki Tabayashi, Ayumi Okuyama, Michihide Tokuhira, Yasuyuki Takahashi, Koichi Amano, Morihiro Higashi, Tatsuki Tomikawa, Shuju Momose, Tomoe Anan-Nemoto, Yuka Tanaka, Masahiro Kizaki, Jun-ichi Tamaru
Publikováno v:
Journal of Clinical and Experimental Hematopathology. 56:165-169
Recently, attention has been focused on methotrexate-induced lymphoproliferative disease (MTX-LPD), and atypical phenotypes are occasionally documented. We encountered two patients with rheumatoid arthritis (RA) who were diagnosed with non-specific L
Autor:
Yuta Kimura, Reiko Watanabe, Takayuki Tabayashi, Michihide Tokuhira, Satoshi Sugiyama, Tomoe Anan-Nemoto, Masahiro Kizaki, Hidenori Oi, Tatsuki Tomikawa, Yasuyuki Takahashi, Makoto Sawano, Morihiko Sagawa, Satoshi Otaki
Publikováno v:
International Journal of Hematology. 105:100-103
Thrombopoietin receptor (TPO-R) agonists have been shown to be effective in refractory chronic immune thrombocytopenia (ITP); however, their efficacy in patients under critical care is not known. We report the case of a female patient with a newly di
Autor:
Yuichi Ishikawa, Naomi Kawashima, Yoshiko Atsuta, Isamu Sugiura, Masashi Sawa, Nobuaki Dobashi, Hisayuki Yokoyama, Noriko Doki, Akihiro Tomita, Toru Kiguchi, Shiro Koh, Heiwa Kanamori, Noriyoshi Iriyama, Akio Kohno, Yukiyoshi Moriuchi, Noboru Asada, Daiki Hirano, Kazuto Togitani, Toru Sakura, Maki Hagihara, Tatsuki Tomikawa, Yasuhisa Yokoyama, Norio Asou, Shigeki Ohtake, Itaru Matsumura, Yasushi Miyazaki, Tomoki Naoe, Hitoshi Kiyoi, Japan Adult Leukemia Study Group
Publikováno v:
SSRN Electronic Journal.
Background: Although acute myeloid leukaemia (AML) with RUNX1-RUNX1T1 and CBFB-MYH11 is categorized into a favorable cytogenetic risk group, several prognostic factors are suggested. However, those clinical significance remains controversial. We aime
Autor:
Yuka, Tanaka, Yasuyuki, Takahashi, Yuta, Kimura, Tatsuki, Tomikawa, Tomoe, Anan, Morihiko, Sagawa, Takayuki, Tabayashi, Reiko, Watanabe, Michihide, Tokuhira, Shuji, Momose, Jun-Ichi, Tamaru, Masahiro, Kizaki
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 59(6)
Human parvovirus B19 (HPV-B19) causes hemophagocytic lymphohistiocytosis (HLH). Here we describe a 35-year-old female with hereditary spherocytosis (HS) who developed HLH due to HPV-B19 infection. Upon admission, she had high fever and diarrhea. Labo
Autor:
Tatsuki Tomikawa, J. Watanabe, Y. Tanaka, Takayuki Tabayashi, R. Nakaseko, Y. Kimura, Michihide Tokuhira, Masahiro Kizaki, T. Anan-Nemoto, Morihiko Sagawa, Y. Takahashi
Publikováno v:
HemaSphere. 3:940
Autor:
Noriyoshi Iriyama, Daiki Hirano, Toru Kiguchi, Heiwa Kanamori, Maki Hagihara, Noboru Asada, Masashi Sawa, Yasushi Miyazaki, Yukiyoshi Moriuchi, Akihiro Tomita, Hisayuki Yokoyama, Yasuhisa Yokoyama, Toru Sakura, Tomoki Naoe, Shigeki Ohtake, Noriko Doki, Naomi Kawashima, Kazuto Togitani, Norio Asou, Hitoshi Kiyoi, Yoshiko Atsuta, Tatsuki Tomikawa, Isamu Sugiura, Itaru Matsumura, Shiro Koh, Nobuaki Dobashi, Akio Kohno, Yuichi Ishikawa
Publikováno v:
Blood. 132:438-438
Background: Recent advance in genetic analysis has revealed that many mutations are associated with the development, progression and/or prognosis of core-binding factor acute myeloid leukemia (CBF-AML). Although KIT mutation is the most frequently id